1. Park E, Kim J. Gender- and age-specific prevalence of metabolic syndrome among Korean adults: analysis of the fifth Korean National Health and Nutrition Examination Survey.
J Cardiovasc Nurs 2015;30(3):256-66.
2. Quiñones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, et al. Effect of insulin on uric acid excretion in humans.
Am J Physiol 1995;268(1 Pt 1):E1-5.
3. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, et al. A causal role for uric acid in fructose-induced metabolic syndrome.
Am J Physiol Renal Physiol 2006;290(3):F625-31.
4. Gagliardi AC, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk.
Atherosclerosis 2009;202(1):11-7.
5. Fu CC, Wu DA, Wang JH, Yang WC, Tseng CH. Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients.
Acta Diabetol 2009;46(2):127-34.
6. Guo L, Cheng Y, Wang X, Pan Q, Li H, Zhang L, et al. Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality.
Acta Diabetol 2012;49(Suppl 1):S65-71.
7. Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, et al. Uric acid and inflammatory markers.
Eur Heart J 2006;27(10):1174-81.
8. Chen N, Wang W, Huang Y, Shen P, Pei D, Yu H, et al. Community-based study on CKD subjects and the associated risk factors.
Nephrol Dial Transplant 2009;24(7):2117-23.
9. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988–1994).
Arch Intern Med 2001;161(9):1207-16.
10. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States.
J Am Soc Nephrol 2002;13(3):745-53.
11. Gu L, Huang L, Wu H, Lou Q, Bian R. Serum uric acid to creatinine ratio: a predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
Diab Vasc Dis Res 2017;14(3):221-5.
12. Durmus Kocak N, Sasak G, Aka Akturk U, Akgun M, Boga S, Sengul A, et al. Serum uric acid levels and uric acid/creatinine ratios in stable chronic obstructive pulmonary disease (COPD) patients: are these parameters efficient predictors of patients at risk for exacerbation and/or severity of disease?
Med Sci Monit 2016;22:4169-76.
14. Li M, Gu L, Yang J, Lou Q. Serum uric acid to creatinine ratio correlates with β-cell function in type 2 diabetes.
Diabetes Metab Res Rev 2018;34(5):e3001.
15. Santos RD. Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander?
Endocrine 2012;41(3):350-2.
16. Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ. Uric acid, evolution and primitive cultures.
Semin Nephrol 2005;25(1):3-8.
17. Reaven G. Why a cluster is truly a cluster: insulin resistance and cardiovascular disease.
Clin Chem 2008;54(5):785-7.
18. Wang HJ, Shi LZ, Liu CF, Liu SM, Shi ST. Association between uric acid and metabolic syndrome in elderly women.
Open Med (Wars) 2018;13:172-7.
19. Chang IH, Han JH, Myung SC, Kwak KW, Kim TH, Park SW, et al. Association between metabolic syndrome and chronic kidney disease in the Korean population.
Nephrology (Carlton) 2009;14(3):321-6.
21. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: a systematic review and metaanalysis.
Clin J Am Soc Nephrol 2011;6(10):2364-73.
22. Tanner RM, Brown TM, Muntner P. Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.
Curr Hypertens Rep 2012;14(2):152-9.
23. Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
Clin J Am Soc Nephrol 2007;2(3):550-62.